1. Home
  2. INFU vs IRWD Comparison

INFU vs IRWD Comparison

Compare INFU & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INFU
  • IRWD
  • Stock Information
  • Founded
  • INFU 2005
  • IRWD 1998
  • Country
  • INFU United States
  • IRWD United States
  • Employees
  • INFU N/A
  • IRWD N/A
  • Industry
  • INFU Medical/Dental Instruments
  • IRWD Biotechnology: Pharmaceutical Preparations
  • Sector
  • INFU Health Care
  • IRWD Health Care
  • Exchange
  • INFU Nasdaq
  • IRWD Nasdaq
  • Market Cap
  • INFU 211.6M
  • IRWD 251.8M
  • IPO Year
  • INFU N/A
  • IRWD 2010
  • Fundamental
  • Price
  • INFU $9.42
  • IRWD $3.34
  • Analyst Decision
  • INFU Strong Buy
  • IRWD Buy
  • Analyst Count
  • INFU 2
  • IRWD 5
  • Target Price
  • INFU $14.50
  • IRWD $5.34
  • AVG Volume (30 Days)
  • INFU 197.4K
  • IRWD 3.6M
  • Earning Date
  • INFU 11-04-2025
  • IRWD 11-10-2025
  • Dividend Yield
  • INFU N/A
  • IRWD N/A
  • EPS Growth
  • INFU 271.43
  • IRWD N/A
  • EPS
  • INFU 0.26
  • IRWD 0.18
  • Revenue
  • INFU $141,054,000.00
  • IRWD $338,987,000.00
  • Revenue This Year
  • INFU $9.02
  • IRWD N/A
  • Revenue Next Year
  • INFU $6.73
  • IRWD N/A
  • P/E Ratio
  • INFU $36.47
  • IRWD $17.84
  • Revenue Growth
  • INFU 6.23
  • IRWD N/A
  • 52 Week Low
  • INFU $4.61
  • IRWD $0.53
  • 52 Week High
  • INFU $11.04
  • IRWD $5.13
  • Technical
  • Relative Strength Index (RSI)
  • INFU 45.22
  • IRWD 76.90
  • Support Level
  • INFU $9.12
  • IRWD $2.96
  • Resistance Level
  • INFU $9.72
  • IRWD $3.44
  • Average True Range (ATR)
  • INFU 0.50
  • IRWD 0.35
  • MACD
  • INFU -0.08
  • IRWD 0.05
  • Stochastic Oscillator
  • INFU 22.61
  • IRWD 87.54

About INFU InfuSystems Holdings Inc.

InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

Share on Social Networks: